Neonatal Pain, Agitation and Sedation Scale (N-PASS)
- Introduced by
- Pam Hummel
- Year
- 2008
- Type
- Clinician-rated
- Family
- pain-sedation-assessment
What does it do?
The N-PASS is a five-item behavioral and physiological assessment tool designed to measure pain, agitation, and sedation in neonates across the full spectrum from profound sedation to severe pain.
Developed by Hummel et al. in 2008, it is validated for both ventilated and non-ventilated infants in NICU settings and provides a rapid bedside assessment combining facial expression, extremity tone, vital sign changes, state of consciousness, and cry characteristics.
The intuition behind the method
The N-PASS integrates behavioral cues (facial grimacing, muscle tone, behavioral state) and physiological indicators (heart rate variability, blood pressure elevation, decreased oxygen saturation) into a unified bidirectional scale. The instrument recognizes that neonatal pain and sedation exist on a continuum and that both require careful titration; it is particularly useful in ventilated infants who cannot communicate distress verbally. Unlike single-domain tools, N-PASS captures the dynamic interaction between pain responsiveness and level of consciousness, essential for optimizing comfort and neurodevelopmental outcomes in the NICU.
History
The N-PASS was developed by Pamela Hummel and colleagues in the NICU at Ohio State University and published in 2008. It emerged from the need for a unified pain and sedation assessment tool that could guide medication management in ventilated neonates, addressing the common clinical problem of simultaneous under-pain-control and over-sedation in the same patient. Subsequent studies (2010–2020) validated the instrument across multiple NICUs and neonatal populations, confirming inter-rater reliability and clinical utility. The N-PASS remains among the most widely adopted neonatal pain-sedation tools in North American NICUs.
When to use it
N-PASS is indicated for all neonates in the NICU, including both ventilated and spontaneously breathing infants. It is particularly valuable for: (1) mechanically ventilated infants requiring sedation/analgesia titration; (2) post-operative neonates; (3) neonates undergoing painful procedures (lumbar puncture, chest tube placement, line insertion); (4) preterm infants (<32 weeks) who have limited behavioral communication; (5) serial monitoring during hospitalization to optimize medication levels and prevent both inadequate pain control and excessive sedation-related complications.
Limitations and considerations
- Vital sign component assumes normal baseline hemodynamics; infants with congenital heart disease, sepsis, or shock may have abnormal baselines requiring adjusted interpretation.
- Behavioral items may be difficult to score accurately in profoundly sedated, paralyzed, or neurologically injured infants where minimal behavioral response occurs.
- Facial expression and extremity tone scoring may be confounded by routine handling, diaper changes, or CPAP/nasal prongs that obscure facial features.
- No formal validation in extreme prematurity (<22 weeks) or in infants with severe neuromuscular disease.
- Does not distinguish between pain and non-pain agitation (e.g., hunger, discomfort, neurological irritability).
Source conditions do not replace independent scientific review or validation by an analysis engine.
Strengths
- Bidirectional scale captures both pain and sedation on a single instrument, avoiding missed over-sedation while treating pain.
- Combines behavioral and physiological indicators, increasing sensitivity to neonatal distress in infants who cannot vocalize discomfort.
- Validated across gestational ages (preterm to term) and acuity levels (non-ventilated to heavily sedated NICU patients).
- Rapid bedside assessment (1–2 minutes) feasible within routine NICU monitoring workflow.
- Strong inter-rater reliability (ICC 0.81–0.89 reported in validation studies) with minimal clinician training required.
Applications
- NICU medication titration: Serial N-PASS scores guide opioid and benzodiazepine dosing in ventilated infants, reducing unnecessary polypharmacy and enabling weaning protocols.
- Post-operative pain management: Following surgical procedures (patent ductus arteriosus ligation, necrotizing enterocolitis repair, emergency delivery), N-PASS quantifies pain and sedation to optimize analgesic regimens.
- Procedure-related pain assessment: Monitoring during routine NICU procedures (peripheral line placement, lumbar puncture, extubation) allows clinicians to assess both immediate pain and sedation adequacy before and after the procedure.
- Quality improvement and benchmarking: Neonatal ICU networks use aggregated N-PASS scores to identify over- or under-sedation patterns, guide staff education, and benchmark sedation practices against best-practice recommendations.
- Medication weaning protocols: Serial N-PASS trends support safe de-escalation of opioids and sedatives by providing objective evidence of decreasing pain/agitation as clinical condition improves.
How it works
How it works
The N-PASS assesses five behavioral and physiological indicators observed over a 1–2 minute period by a bedside nurse or clinician. No special equipment is required beyond standard NICU monitoring (heart rate, blood pressure, oxygen saturation). Observations include crying/irritability, behavioral state, facial expression, extremity tone, and vital sign changes. Assessment takes approximately 2 minutes and can be performed at any time, with particular utility during care procedures or medication adjustments.
Each of the five items is scored on a scale from -2 (most sedated) to +2 (most agitated/pained). Scoring rules: Crying/Irritability: -2 (no cry, sedated), -1 (whimpering, reacting), 0 (baseline), +1 (high-pitched cry), +2 (inconsolable crying). Behavioral State: -2 (sleeping deeply), -1 (difficult to arouse), 0 (awake, calm), +1 (restless, agitated), +2 (hyperalert, frantic). Facial Expression: -2 (no expression, eyes closed), -1 (minimal expression), 0 (neutral), +1 (grimace), +2 (severe grimace). Extremity Tone: -2 (flaccid, no tone), -1 (decreased tone), 0 (normal), +1 (increased tone), +2 (rigid, clenched fists). Vital Signs: -2 (HR <80, SBP <50 mmHg), -1 (HR 80–100, SBP 50–60 mmHg), 0 (baseline), +1 (HR increase 20%, SBP increase 10–20%), +2 (HR increase >20%, SBP increase >20%). Total score ranges from -10 (maximum sedation) to +10 (maximum pain/agitation).
Scores are interpreted as follows: -10 to -5: Excessive sedation (unresponsiveness, risk of apnea and hypotension). -4 to 0: Appropriate sedation or comfort (desired target for sedated/intubated infants). +1 to +4: Mild to moderate pain/agitation (may require mild analgesic or sedative adjustment). +5 to +10: Severe pain or agitation (requires immediate intervention with analgesia or sedation). Serial monitoring every 2–4 hours (or more frequently during acute procedures) allows trend assessment and medication titration. The bidirectional scale allows clinicians to avoid both under- and over-sedation, optimizing comfort while maintaining adequate neurocognitive responsiveness.
Common pitfalls
- Over-reliance on vital signs alone without behavioral context; tachycardia and hypertension may reflect fever, sepsis, or anemia rather than pain, leading to unnecessary opioid escalation.
- Scoring behavioral state in sedated infants; mistaking physiological sedation (closed eyes, minimal movement) for adequate comfort when the underlying painful stimulus remains unaddressed.
- Failure to reassess after medication administration; clinicians must observe response to analgesic or sedative changes and adjust doses iteratively rather than relying on a single baseline score.
- Misapplication to non-NICU populations (e.g., pediatric ICU beyond neonatal period) where the scale's neonatal-specific criteria may not apply.
Frequently asked questions
What is the difference between N-PASS and other neonatal pain scales like PIPP?
The PIPP (Premature Infant Pain Profile) focuses narrowly on acute procedural pain and includes gestational age weighting; N-PASS is broader, covering both pain and sedation across a wider spectrum and applicable to any clinical context (procedural, post-operative, chronic discomfort). N-PASS is bidirectional (-10 to +10) whereas PIPP is unidirectional (0–21 pain only). Choice depends on clinical context: PIPP for acute procedures in preterm infants; N-PASS for ongoing NICU management of ventilated patients.
How often should N-PASS be performed in a ventilated neonate?
Current best practice recommends N-PASS assessment every 2–4 hours for baseline monitoring, with additional assessments before and after painful procedures, medication adjustments, or significant clinical changes. Some NICUs using sedation protocols perform every-hour reassessment during acute phases of illness; protocols vary by institution. Documentation of time, score, and action taken (medication change, non-pharmacological intervention) supports continuity of care.
Can N-PASS be reliably scored in a paralyzed, deeply sedated infant?
Scoring in paralyzed infants is challenging because behavioral items (facial expression, extremity tone, behavioral state) cannot be observed when neuromuscular blockade is active. In this context, clinicians must rely more heavily on vital sign changes and clinical context, recognizing that the behavioral portion of N-PASS is limited. Some NICUs recommend scoring only the vital sign component or using alternative tools (e.g., pharmacokinetic/pharmacodynamic drug level monitoring) when paralysis precludes behavioral observation.
What are target N-PASS scores for different clinical scenarios?
For mechanically ventilated neonates requiring sedation, target N-PASS scores typically range from -2 to +2 (light sedation with arousability) to 0 to +2 (minimal sedation) depending on institutional protocol and clinical stability. Post-extubation, scores of -1 to +1 are often targeted to minimize re-intubation risk while maintaining comfort. For non-intubated infants, scores near 0 reflect comfort. Scores persistently above +4 warrant analgesic escalation; scores below -4 warrant sedative reduction to avoid excessive suppression.
Related methods
Sources
Hummel, P., Puchalski, M., Creech, S. D., & Weiss, M. G. (2008). Clinical Reliability and Validity of the N-PASS: Neonatal Pain, Agitation and Sedation Scale with Prolonged Ventilation Patients. Journal of Perinatology, 28(1), 55-60.
Open DOI referenceCopied.Hummel, P. (2008). Neonatal Pain, Agitation and Sedation Scale. Advances in Neonatal Care, 8(5), 285-287.
Open publication referenceCopied.